NASDAQ: NGNE 31.15%
Neurogene Shares Rally on FDA Breakthrough Therapy Designation for Rett Syndrome Therapy
NASDAQ: ENSC 73.31%
Expected US Company Earnings on Tuesday, November 11th, 2025
NASDAQ: EDSA 47.03%
$38M Defense Backlog vs. $6M Market Cap, Breakthrough Biotech Data, and the Quantum Security Land Grab
NASDAQ: MGN 34.5%
Megan Holdings Limited Announces Closing of $8.3 Million Follow-on Public Offering
NYSE: KORE 77.39%
KORE Reports Third Quarter 2025 Results
NYSE: BATL 21.08%
Halftime Market Summary: Stocks to Watch before Super Bowl Weekend
NYSE: NGNE 73.31%
NYSE: ENSC 73.31%
NYSE: EDSA 73.31%
NYSE: MGN 73.31%
NYSE: KORE 73.31%
